Pear Therapeutics Adds QuickMD To Its Telehealth Initiative For Virtual Treatment Of Opioid Use Disorder

Pear Therapeutics, Inc., which develops and commercializes prescription digital therapeutics (PDTs), partnered with QuickMD, a telemedicine platform to expand access to virtual treatment for opioid use disorder (OUD) augmented with Pear’s reSET-O PDT. QuickMD is Pear’s second telehealth offering for re-SET-O. Pear added QuickMD to its “find a provider tool,” which also displays in-person care options for addiction treatment that incorporates re-SET-O.

Pear’s reSET-O, for the treatment of OUD, has been measured in real-world use and its therapeutic content studied in randomized controlled trials, with results published in peer . . .